Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Comment by duskwon Oct 03, 2012 12:39pm
300 Views
Post# 20443033

RE: RE: RE: Impressive.

RE: RE: RE: Impressive.

Interesting point of view, omahacorn. A few points to clarify. Yes the new CEO was a BOD member. But he actually owned and was the CEO of Outback before they were bought by (now) Hemisphere.

They are not broke, but they are definitely running defecits. The main reason, IMO, is the expenses are too high. This can be remedied either by cutting costs or leveraging on economies of scale (i.e. merger or takeover).

I think most people on this board are investors who have watched with astonishment as the company has failed again and again to capitalize on a growing market where other competitors seem to be making a lot of money.

That said, they have a new premiere product that should generate some new business and revenue as well as a growing software services component that seems to add a lot of value to the end customer. Hoepfully those things combined will be a catalyst for the next year or so and generate enough interested in HEM to be taken over.

 

Bullboard Posts